Can ctDNA-guided therapy stop cancer’s return, sparing patients unnecessary treatment? A new study suggests it might.

5."It felt like an extremely well-rounded profession. You get to do inpatient and outpatient. You get to do office procedures ...

David Polsky, MD, discussed a study showing ctDNA levels before melanoma treatment strongly predict recurrence and its speed, ...

Monitoring blood levels of circulating tumor DNA in patients with stage 3 melanoma may accurately predict skin cancer recurrence, according to results from a phase 3 study published in The Lancet ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Medicare Administrative Contractors (MACs), which most Americans have never heard of, pose a perilous hazard to your health.

Baystreet.ca News Commentary – Innovation in biotech is rapidly reshaping how we fight cancer, a trend reflected in the ...

Ovarian cancer, often termed a silent killer, remains underdiagnosed due to vague symptoms and lack of screening. With high ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

Study suggests these antioxidant-rich juices may be a well-tolerated, practical addition to standard childhood asthma ...

Our recent webinar series, ‘Unlocking Precision Oncology’s Full Potential through Next-Gen Molecular Analysis’, showcased ...